Reaction Details | |||
---|---|---|---|
Report a problem with these data | |||
Target | Vitamin D3 receptor | ||
Ligand | BDBM263421 | ||
Substrate/Competitor | n/a | ||
Meas. Tech. | Dopamine D3 Receptor Binding Test | ||
Ki | 0.093±n/a nM | ||
Citation | Li, J; Chen, X; Ma, Z; Zhang, L; Cui, N Benzoisothiazole compounds and methods of treating schizophrenia US Patent US9550741 Publication Date 1/24/2017 | ||
More Info.: | Get all data from this article, Assay Method | ||
Vitamin D3 receptor | |||
Name: | Vitamin D3 receptor | ||
Synonyms: | 1,25-dihydroxyvitamin D3 receptor | NR1I1 | Nuclear receptor subfamily 1 group I member 1 | Retinoic acid receptor RXR-alpha/Vitamin D3 receptor | VDR | VDR_HUMAN | ||
Type: | Protein | ||
Mol. Mass.: | 48288.72 | ||
Organism: | Homo sapiens (Human) | ||
Description: | P11473 | ||
Residue: | 427 | ||
Sequence: |
| ||
BDBM263421 | |||
n/a | |||
Name | BDBM263421 | ||
Synonyms: | US9550741, III-3 | ||
Type | Small organic molecule | ||
Emp. Form. | C24H36N4O2S | ||
Mol. Mass. | 444.633 | ||
SMILES | CC(C)COC(=O)N[C@H]1CC[C@H](CCN2CCN(CC2)c2nsc3ccccc23)CC1 |r,wU:8.7,wD:11.11,(-11.6,2.16,;-10.27,2.93,;-10.27,4.47,;-8.93,2.16,;-7.6,2.93,;-6.26,2.16,;-6.26,.62,;-4.93,2.93,;-3.6,2.16,;-2.26,2.93,;-.93,2.16,;-.93,.62,;.4,-.15,;1.74,.62,;3.07,-.15,;3.07,-1.69,;4.4,-2.46,;5.74,-1.69,;5.74,-.15,;4.4,.62,;7.07,-2.46,;7.07,-4,;8.54,-4.47,;9.44,-3.23,;10.97,-3.07,;11.6,-1.66,;10.69,-.41,;9.16,-.57,;8.54,-1.98,;-2.26,-.15,;-3.6,.62,)| | ||
Structure |